AVITA Medical, Inc. - Common Stock (RCEL)

CUSIP: 05380C102

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
30,540,782
Total 13F shares
6,867,607
Share change
-603,217
Total reported value
$58,179,804
Put/Call ratio
21%
Price per share
$8.48
Number of holders
65
Value change
-$8,054,352
Number of buys
34
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 05380C102?
CUSIP 05380C102 identifies RCEL - AVITA Medical, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q1 2022

As of 31 Mar 2022, AVITA Medical, Inc. - Common Stock (RCEL) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,867,607 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, PURA VIDA INVESTMENTS, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, AMERIPRISE FINANCIAL INC, and RTW INVESTMENTS, LP. This page lists 65 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.